You are here

drug pricing

High U.S. drug prices cover pharma's global R&D—and a whole lot more, study finds

Fierce Pharma

Fri, 03/10/17 - 11:41 am

Trump 'enthusiastic' about drug price negotiation, lawmakers say

BioPharma Dive

Thu, 03/9/17 - 11:31 am

Cummings uses Trump drug-price meeting to push Medicare negotiation plan

Fierce Pharma

Thu, 03/9/17 - 09:48 am

Elijah Cummings

Do big R&D budgets justify US premium drug prices? No way, analysts scoff

Endpoints

Wed, 03/8/17 - 10:44 am

drug development

In quick rebuttal, Express Scripts blasts Gilead exec's pricing blame

Fierce Pharma

Wed, 03/8/17 - 10:42 am

Express Scripts

Gilead Sciences

Drugmakers fall as investors see pricing threat from Trump

Yahoo/AP

Wed, 03/8/17 - 09:47 am

Drug price moves in ACA repeal? Nope. But a Trump tweet says a 'new system' is coming

Fierce Pharma

Tue, 03/7/17 - 12:05 pm

Eight senators pile on to Marathon's Emflaza—and its $89,000 pricing blunder

Fierce Pharma

Mon, 03/6/17 - 11:55 am

Marathon Pharma

Germany to scrap plan to lower prices of new drugs-lawmakers

Yahoo/Reuters

Mon, 03/6/17 - 09:50 am

Gilead Executive Says Pharmacy Benefit Managers Keep Prices High

Bloomberg

Fri, 03/3/17 - 10:29 pm

Gilead Sciences

Twenty More States Accuse Mylan, Teva and Others of Price Collusion

TheStreet.com

Thu, 03/2/17 - 10:45 am

Teva Pharmaceutical

price collusion

Big Pharma Pushes Back on Drug-Price Complaints

Investopedia

Wed, 03/1/17 - 09:22 pm

The world's biggest drugmaker just pulled back the curtain on drug pricing

Yahoo/Business Insider

Mon, 02/27/17 - 10:29 pm

Why drug pricing seems so complicated

BioPharma Dive

Mon, 02/27/17 - 11:12 am

Top pharma lobbyist casts Biogen as the anti-Shkreli during drug price Q&A

Bizjournals.com

Tue, 02/21/17 - 10:26 pm

Did Biogen Inc. Shoot Itself in the Foot?

Motley Fool

Tue, 02/21/17 - 11:11 am

spinal muscular atrophy

Shkreli defends drug prices, spars with protesters at heated UMass Boston event

Bizjournals.com

Fri, 02/17/17 - 09:48 am

PhRMA disses Marathon CEO—and PhRMA board member—Jeff Aronin after latest price gouging controversy

Endpoints

Thu, 02/16/17 - 03:12 pm

Marathon Pharma

The E100: Biotech execs are bullish about 2017, but fret about drug pricing and the FDA under Trump

Endpoints

Wed, 02/15/17 - 10:00 am

biotech executives

Marathon halts launch of DMD drug as $89K price attracts congressional heat

Fierce Pharma

Tue, 02/14/17 - 12:12 pm

Marathon Pharma

Duchenne Muscular Dystrophy

Pages